Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year


Summary for Tradename: PEPCID COMPLETE

Suppliers: see list1
patent expirations by year for

Clinical Trials for: PEPCID COMPLETE

Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)
Status: Completed Condition: Osteoarthritis; Rheumatoid Arthritis; Chronic Low Back Pain; Chronic Regional Pain Syndrome; Chronic Soft Tissue Pain

A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer
Status: Completed Condition: Cancer

Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia
Status: Recruiting Condition: Aspirin; Dyspepsia

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer
Status: Recruiting Condition: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer

Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
Status: Recruiting Condition: Recurrent Breast Cancer; Metastatic Breast Cancer

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Cons
calcium carbonate; famotidine; magnesium hydroxide
TABLET, CHEWABLE;ORAL020958Oct 16, 2000OTCYes5,989,588*PED<disabled>Y<disabled>
Mcneil Cons
calcium carbonate; famotidine; magnesium hydroxide
TABLET, CHEWABLE;ORAL020958Oct 16, 2000OTCYes6,814,978*PED<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PEPCID COMPLETE

Drugname Dosage Strength RLD Submissiondate
calcium carbonate/ famotadine/ magnesium hydroxideChewable Tablets800 mg/ 10 mg/ 165 mg (OTC)Pepcid Complete11/1/2004

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology